Sign In
Last checked at 
30 Jan 2025 17:49
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
CA68234M2058
Issuer Name
ONDINE BIOMEDICAL INC
UK or Non-UK Issuer
Non-UK
2. Reason for Notification
Other
Comments
New shares were issued diluting ownership.
3. Details of person subject to the notification obligation
Name
Carolyn Cross
City of registered office (if applicable)
Vancouver
Country of registered office (if applicable)
Canada
4. Details of the shareholder
Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above
City of registered office (if applicable)
Country of registered office (if applicable)
5. Date on which the threshold was crossed or reached
29-Jan-2025
6. Date on which Issuer notified
29-Jan-2025
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights held in issuer | |
Resulting situation on the date on which threshold was crossed or reached | 26.715201 | 0.000000 | 26.715201 | 118,091,377 |
Position of previous notification (if applicable) | 29.230197 | 0.000000 | 29.230197 | 118,091,377 |
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible) | Number of direct voting rights (DTR5.1) | Number of indirect voting rights (DTR5.2.1) | % of direct voting rights (DTR5.1) | % of indirect voting rights (DTR5.2.1) |
CA68234M2058 | 65,884,085 | 52,207,292 | 14.904615 | 11.810585% |
Sub Total 8.A | 118,091,377 | 26.715201 | ||
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument | Expiration date | Exercise/conversion period | Number of voting rights that may be acquired if the instrument is exercised/converted | % of voting rights |
| ||||
Sub Total 8.B1 | ||||
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial instrument | Expiration date | Exercise/conversion period | Physical or cash settlement | Number of voting rights | % of voting rights |
| |||||
Sub Total 8.B2 | |||||
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
Ultimate controlling person | Name of controlled undertaking | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold |
Carolyn Cross | Carolyn Cross | 26.715201 | 26.715201 | |
Carolyn Cross | 0902337 B.C. Ltd (wholly owned by Carolyn Cross) | 26.715201 | 26.715201 | |
Carolyn Cross | Vencourt Capital Ltd (wholly owned by Carolyn Cross) | 26.715201 | 26.715201 | |
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
12. Date of Completion
30-Jan-2025
13. Place Of Completion
Vancouver, Canada
Follow the stocks
